cAMP signaling can antagonize potent glucocorticoid post-transcriptional inhibition of stanniocalcin gene expression

Journal of Endocrinology

Volumn 171, Issue 3, 2001, Pages 499-516

  Groves, T C ^a   Wagner, G F ^a   DiMattia, G E ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DACTINOMYCIN; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ANTAGONIST; GLYCOPROTEIN; HYDROCORTISONE; HYPOCALCIN; MESSENGER RNA; MIFEPRISTONE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CANCER CELL CULTURE; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; FIBROSARCOMA; GENE EXPRESSION REGULATION; GENE REPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHOSPHATE TRANSPORT; PRIORITY JOURNAL; PROTEIN PROCESSING; STEADY STATE;

ANIMALS; CELL CULTURE TECHNIQUES; CELL LINE; CULTURE MEDIA; CYCLIC AMP; DEXAMETHASONE; DOWN-REGULATION; GENE EXPRESSION REGULATION; GENES, REPORTER; GLUCOCORTICOIDS; GLYCOPROTEINS; HORMONES; HYDROCORTISONE; MICE; MIFEPRISTONE; PITUITARY GLAND, ANTERIOR; RECEPTORS, GLUCOCORTICOID; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0035664390     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1710499     Document Type: Article

References (83)

1. Hormonal regulation of POMC gene expression
2. Activin-A inhibits proopiomelanocortin messenger RNA accumulation and adrenocorticotropin secretion of AtT20 cells
3. Developmental and hormonal regulation of surfactant protein C (SP-C) gene expression in fetal lung. Role of transcription and mRNA stability
4. Purification and cloning of a corpuscles of Stannius protein from Anguilla australis
5. Differential activity of ELAV-like RNA-binding proteins in human neuroblastoma
6. A novel human cDNA highly homologous to the fish hormone stanniocalcin
7. Molecular cloning and characterization of mouse stanniocalcin cDNA
8. Repression of the human glycoprotein hormone alpha-subunit gene by glucocorticoids: Evidence for receptor interactions with limiting transcriptional activators
9. Nuclear receptors: Coactivators, corepressors and chromatin remodeling in the control of transcription
10. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: Negative interference of activated glucocorticoid receptor with transcription factors
11. Immunolocalization of stanniocalcin in human kidney
12. Development of a human stanniocalcin radioimmunoassay: Serum and tissue hormone levels and pharmacokinetics in the rat
13. Glucocorticoid receptor binding to a specific DNA sequence is required for hormone-dependent repression of pro-opiomelanocortin gene transcription
14. Novel glucocorticoid receptor complex with DNA element of the hormone-repressed POMC gene
15. Post-transcriptional regulation of the stanniocalcin gene by calcium
16. Glucocorticoid-mediated destabilization of cyclin D3 mRNA involves RNA-protein interactions in the 3′-untranslated region of the mRNA
17. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation
18. The multifunctional role of the co-activator CBP in transcriptional regulation
19. Identification of newly transcribed RNA
20. Negative glucorticoid regulation of cyclic adenosine 3′, 5′-monophosphate-stimulated corticotropin-releasing hormone-reporter expression in AtT-20 cells
21. Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide responsive sequence in the type-1 plasminogen activator inhibitor mRNA
22. Regulation by 1 alpha,25-dihydroxyvitamin D(3) of expression of stanniocalcin messages in the rat kidney and ovary
23. SP-A 3′-UTR is involved in the glucocorticoid inhibition of human SP-A gene expression
24. Chromogranin A does not mediate glucocorticoid inhibition of adrenocorticotropin secretion
25. The transcriptional program in the response of human fibroblasts to serum
26. Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells
27. The distribution of stanniocalcin 1 protein in fetal mouse tissues suggests a role in bone and muscle development
28. p21(waf1) mRNA contains a conserved element in its 3′-untranslated region that is bound by the Elav-like mRNA-stabilizing proteins
29. Gene expression profiling in an in vitro model of angiogenesis
30. Dexamethasone rapidly induces a novel ras superfamily member-related gene in AtT-20 cells
31. CRF and cAMP regulation of POMC gene expression in corticotrophic tumor cells
32. AUUUA is not sufficient to promote poly(A) shortening and degradation of an mRNA: The functional sequence within AU-rich elements may be UUAUUUA(U/A)(U/A)
33. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38
34. Cyclic nucleotide regulation of Na+/glucose cotransporter (SGLT1) mRNA stability. Interaction of a nucleocytoplasmic protein with a regulatory domain in the 3′-untranslated region critical for stabilization
35. Glucocorticoids inhibit somatostatin gene expression through accelerated degradation of somatostatin messenger ribonucleic acid in human thyroid medullary carcinoma (TT) cells
36. Glucocorticoids activate somatostatin gene transcription through co-operative interaction with the cyclic AMP signalling pathway
37. Stanniocalcin stimulates phosphate reabsorption by flounder renal proximal tubule in primary culture
38. Hormone secretagogues increase cytosolic calcium by increasing cAMP in corticotropin-secreting cells
39. Regulation of proopiomelanocortin gene expression in pituitary
40. Stanniocalcin: A novel protein regulating calcium and phosphate transport across mammalian intestine
41. Composite glucocorticoid regulation at a functionally defined negative glucocorticoid response element of the human corticotropin-releasing hormone gene
42. Glucocorticoid regulation of metallothionein-I mRNA synthesis in cultured mouse cells
43. The rat glucocorticoid receptor mutant K461A differentiates between two different mechanisms of transrepression
44. RU 38486: Potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation
45. Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells
46. Human stanniocalcin: A possible hormonal regulator of mineral metabolism
47. Nucleoprotein structure influences the response of the mouse mammary tumor virus promoter to activation of the cyclic AMP signalling pathway
48. Dexamethasone inhibits insulin biosynthesis by destabilizing insulin messenger ribonucleic acid in hamster insulinoma cells
49. Identification of a novel dexamethasone-sensitive RNA-destabilizing region on rat monocyte chemoattractant protein 1 mRNA
50. Beta-adrenergic agonists that down-regulate receptor mRNA up-regulate a M(r) 35,000 protein(s) that selectively binds to beta-adrenergic receptor mRNAs
51. The destabilization of IL-2 mRNA by a premature stop codon and its differential stabilization by trans-acting inhibitors of protein synthesis do not support a role for active translation in mRNA stability
52. Corticotropin-releasing factor-induced adrenocorticotropin hormone release and synthesis is blocked by incorporation of the inhibitor of cyclic AMP-dependent protein kinase into anterior pituitary tumor cells by liposomes
53. Glucocorticoid regulation of cyclin D3 gene transcription and mRNA stability in lymphoid cells
54. Cyclic adenosine-3′,5′-monophosphate-mediated activation of a glutamine synthetase composite glucocorticoid response element
55. What is a cAMP response unit?
56. Changes of gene expression by lysophosphatidylcholine in vascular endothelial cells: 12 up-regulated distinct genes including 5 cell growth-related, 3 thrombosis-related, and 4 others
57. Regulation of stanniocalcin in MDCK cells by hypertonicity and extracellular calcium
58. Signal pathways mediating oxytocin stimulation of prostaglandin synthesis in select target cells
59. Stanniocalcin gene expression during mouse urogenital development: A possible role in mesenchymal-epithelial signalling
60. Studies on the mechanism of glucocorticoid-mediated repression from a negative glucocorticoid response element from the bovine prolactin gene [published erratum appears in DNA]
61. Chum salmon (Oncorhynchus keta) stanniocalcin inhibits in vitro intestinal calcium uptake in Atlantic cod (Gadus morhua)
62. Catalytic mechanism and regulation of mammalian adenylyl cyclases
63. Molecular determinants for cell specificity and glucocorticoid repression of the proopiomelanocortin gene
64. Protein kinase A stimulates binding of multiple proteins to a U-rich domain in the 3′-untranslated region of lactate dehydrogenase A mRNA that is required for the regulation of mRNA stability
65. Cyclic nucleotide regulation of PAI-1 mRNA stability. Identification of cytosolic proteins that interact with an a-rich sequence
66. Comparative analysis of mammalian stanniocalcin genes
67. The molecular biology of the corpuscles of stannius and regulation of stanniocalcin gene expression
68. Calcium regulates stanniocalcin mRNA levels in primary cultured rainbow trout corpuscles of Stannius
69. Purification, characterization, and bioassay of teleocalcin, a glycoprotein from salmon corpuscles of Stannius
70. Comparative biochemistry and physiology of teleocalcin from sockeye and coho salmon
71. Primary culture of teleocalcin cells from rainbow trout corpuscles of Stannius: Regulation of teleocalcin secretion by calcium
72. Studies on the regulation and characterization of plasma stanniocalcin in rainbow trout
73. Immunological and biological evidence for a stanniocalcin-like hormone in human kidney
74. Human stanniocalcin inhibits renal phosphate excretion in the rat
75. Glucose starvation reduces IGF-I mRNA in tumor cells: Evidence for an effect on mRNA stability
76. Proliferation of the murine corticotropic tumour cell line AtT20 is affected by hypophysiotrophic hormones, growth factors and glucocorticoids
77. Reconstitution of angiotensin receptor mRNA down-regulation in vascular smooth muscle. Post-transcriptional control by protein kinase A but not mitogenic signaling directed by the 5′-untranslated region
78. Glucocorticoids increase fatty-acid synthase mRNA stability in fetal rat lung
79. Glucocorticoid effects in the human placenta: Evidence that dexamethasone-mediated inhibition of fibronectin expression in cytotrophoblasts involves a protein intermediate
80. Evidence for stanniocalcin gene expression in mammalian bone
81. A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor
82. High expression of stanniocalcin in differentiated brain neurons
83. Stanniocalcin: A molecular guard of neurons during cerebral ischemia